Campbell, Erin K. http://orcid.org/0000-0002-6314-1164
Campbell, Thomas M.
Culakova, Eva
Blanchard, Lisa
Wixom, Nellie
Guido, Joseph J.
Fetten, James
Huston, Alissa
Shayne, Michelle
Janelsins, Michelle C.
Mustian, Karen M.
Moore, Richard G.
Peppone, Luke J.
Clinical trials referenced in this document:
Documents that mention this clinical trial
A whole food, plant-based randomized controlled trial in metastatic breast cancer: feasibility, nutrient, and patient-reported outcomes
https://doi.org/10.1007/s10549-024-07284-z
A whole-food, plant-based dietary intervention and cognitive function in women with metastatic breast cancer.
https://doi.org/10.1200/jco.2023.41.16_suppl.e24160
A whole-food, plant-based randomized controlled trial in metastatic breast cancer: weight, cardiometabolic, and hormonal outcomes
https://doi.org/10.1007/s10549-024-07266-1
Funding for this research was provided by:
Highland Hospital Foundation
National Institutes of Health (UG1-CA189961)
Article History
Received: 10 October 2023
Accepted: 7 February 2024
First Online: 30 March 2024
Declarations
:
: TMC: Royalties from general interest books about plant-based nutrition (Benbella Books, Penguin Random House) and income from a lifestyle medicine practice, Thomas M. Campbell, MD PLLC; EKC: Conflicts of spouse (TMC); AH: MJH Healthcare Holdings (OncLive), Mediflix (Skipta/Informa); RGM: Consultant for Fujirebio Diagnostics and research funding from Angle, PLC. The rest of the authors declare no competing interests.
: This study was conducted in accordance with the U.S. Common Rule. The study protocol was approved by the University of Rochester Research Subject Review Board (ClinicalTrials.gov identifier: NCT03045289; registration 7 February 2017).
: Written informed consent was obtained from all participants.
: Not applicable.